Cargando…
The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation
OBJECTIVE: Oxidized Low-Density-Lipoprotein (Ox-LDL) is the core factor in the development of atherosclerosis. However, there are few therapies aimed at eliminating Ox-LDL. Here in this study, we investigate whether the ectopically expression of the lectin-like oxidized low density lipoprotein recep...
Autores principales: | Wang, Zhiwen, Chen, Juan, Zeng, Zhuanglin, Zhang, Qing, Du, Gaohui, Guo, Xiaopeng, Wei, Yumiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889706/ https://www.ncbi.nlm.nih.gov/pubmed/35236285 http://dx.doi.org/10.1186/s10020-022-00450-3 |
Ejemplares similares
-
Reducing the Damage of Ox-LDL/LOX-1 Pathway to Vascular Endothelial Barrier Can Inhibit Atherosclerosis
por: Guo, Xiaopeng, et al.
Publicado: (2022) -
Elimination of Ox-LDL through the liver inhibits advanced atherosclerotic plaque progression
por: Wang, Zhiwen, et al.
Publicado: (2021) -
LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013) -
Dyslipidemia-Induced Neuropathy in Mice: The Role of oxLDL/LOX-1
por: Vincent, Andrea M., et al.
Publicado: (2009) -
MicroRNA-98 rescues proliferation and alleviates ox-LDL-induced apoptosis in HUVECs by targeting LOX-1
por: Chen, Zhibo, et al.
Publicado: (2017)